Brighton Jones’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Other funds holding HUMA
Brighton Jones's HUMA Position: Q3 2026 in Review
Brighton Jones sold out of Humacyte (HUMA) in Q3 2026, closing a stake of 35,726 shares — an estimated $27.9K sold.
Brighton Jones first reported a position in HUMA in Q1 2026 and held it in 2 quarters. The position peaked at $27.9K in Q2 2026. 110 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.
- Brighton Jones reported no remaining Humacyte position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 35,726 Humacyte shares in Q3 2026, an estimated $27.9K.
- Brighton Jones first reported a position in Humacyte in Q1 2026 and held it in 2 quarters.
- Brighton Jones's Humacyte position peaked at $27.9K in Q2 2026.
- 110 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.